foxo4-dri senolytic peptide study 2017 cell

foxo4-dri senolytic peptide study 2017 cell FOXO4 - an overview Peptide inhibitors targeting FOXO4-p53 interactions

Name: foxo4-dri senolytic peptide study 2017 cell FOXO4 - an overview Peptide inhibitors targeting FOXO4-p53 interactions
Brand: astonvaughan.co.uk
SKU: 2093322476
Price: 24.78 USD
Availability: InStock
Rating: 4.0567 (12 reviews)

Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv FOXO4 DRI: The Senolytic Peptide That Targets Zombie Cells and Aging Revolution Health & Wellness The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Full article: Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics

SKU: 2093322476 · From astonvaughan.co.uk

4.1

USD24.78 USD71.78

Pay in 4 interest-free payments of $6.20 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

You can stop shipments at any time in your customer account or by calling our customer support team toll free at (888) 558-9836, Mon - Sun 24/7, Outside the US, call us at +1-863-301-4007

Approved EFSA Health Claims for Vitamin B12: Contributes to normal energy-yielding metabolism and the reduction of tiredness and fatigue Contributes to the normal functioning of the nervous system Contributes to normal homocysteine metabolism, psychological function and red blood cell formation Contributes to the normal function of the immune system Made in the UK